Lacticaseibacillus Paracasei Subsp. Tolerans-Stamm und Verwendungen davon

Details

Veröffentlichungs-Nr.

EP4781997

Anmeldetag

28. Januar 2025

Veröffentlichung

29. Juli 2026

Rechtsraum

EP

Abstract

The invention is in the field of biomedicine; and relates to Lacticaseibacillus paracasei subsp. tolerans, and a specific strain or a variant thereof, and their use in the treatment of insulin resistance syndrome, polycystic ovary syndrome, insulin resistance related infertility, gestational diabetes, obesity, and proinflammatory conditions. The invention also relates to a biologically pure culture, or a composition, or a pharmaceutical product, or a feed, or a nutritional product, or a nutraceutical composition comprising the specific strain or variant thereof, and a cosmetic method comprising administering the specific strain, or the biologically pure culture, composition, pharmaceutical product, feed, nutritional product, or nutraceutical composition.

Anmelder

Firma

Kerry Group Services International Limited

Land

🇮🇪 Irland